Fig. 1
Kaplan–Meier plots of median A progression-free survival (PFS), B time-to-progression (TTP), and C overall survival (OS) in patients treated with TACE plus regorafenib
Fig. 1 | BMC Gastroenterology
Kaplan–Meier plots of median A progression-free survival (PFS), B time-to-progression (TTP), and C overall survival (OS) in patients treated with TACE plus regorafenib